Gene delivery to differentiated neurotypic cells with RGD and HIV Tat peptide functionalized polymeric nanoparticles

被引:131
作者
Suk, Jung Soo
Suh, Junghae
Choy, Kokleong
Lai, Samuel K.
Fu, Jie
Hanes, Justin
机构
[1] Johns Hopkins Univ, Dept Chem & Biomol Engn, Baltimore, MD 21218 USA
[2] Johns Hopkins Univ, Dept Biomed Engn, Baltimore, MD 21218 USA
关键词
gene therapy; CNS diseases; polymers; polyethylenimine (PEI);
D O I
10.1016/j.biomaterials.2006.05.013
中图分类号
R318 [生物医学工程];
学科分类号
0831 ;
摘要
A number of neurodegenerative disorders may potentially be treated by the delivery of therapeutic genes to neurons. Nonviral gene delivery systems, however, typically provide low transfection efficiency in post-mitotic differentiated neurons. To uncover mechanistic reasons for this observation, we compared gene transfer to undifferentiated and differentiated SH-SY5Y cells using polyethylenimine (PEI)/DNA nanocomplexes. Differentiated cells exhibited substantially lower uptake of gene vectors. To overcome this bottleneck, RGD or HIV-1 Tat peptides were attached to PEI/DNA nanocomplexes via poly(ethylene glycol) (PEG) spacer molecules. Both RGD and Tat improved the cellular uptake of gene vectors and enhanced gene transfection efficiency of primary neurons up to 14-fold. RGD functionalization resulted in a statistically significant increase in vector escape from endosomes, suggesting it may improve gene delivery by more than one mechanism. (c) 2006 Elsevier Ltd. All rights reserved.
引用
收藏
页码:5143 / 5150
页数:8
相关论文
共 62 条
  • [21] Polyethylenimine improves the transfection efficiency of primary cultures of post-mitotic rat fetal hypothalamic neurons
    Guerra-Crespo, M
    Charli, JL
    Rosales-García, VH
    Pedraza-Alva, G
    Pérez-Martínez, L
    [J]. JOURNAL OF NEUROSCIENCE METHODS, 2003, 127 (02) : 179 - 192
  • [22] Increase of antioxidative potential by tert-butylhydroquinone protects against cell death associated with 6-hydroxydopamine-induced oxidative stress in neuroblastoma SH-SY5Y cells
    Hara, H
    Ohta, M
    Ohta, K
    Kuno, S
    Adachi, T
    [J]. MOLECULAR BRAIN RESEARCH, 2003, 119 (02): : 125 - 131
  • [23] Targeting of Lipid-Protamine-DNA (LPD) lipopolyplexes using RGD motifs
    Harvie, P
    Dutzar, B
    Galbraith, T
    Cudmore, S
    O'Mahony, D
    Anklesaria, P
    Paul, R
    [J]. JOURNAL OF LIPOSOME RESEARCH, 2003, 13 (3-4) : 231 - 247
  • [24] Polyethyleneimine-mediated transfection of cultured postmitotic neurons from rat sympathetic ganglia and adult human retina
    Horbinski, Craig
    Stachowiak, Michal K.
    Higgins, Dennis
    Finnegan, Sarah G.
    [J]. BMC NEUROSCIENCE, 2001, 2 (1)
  • [25] Gene therapy for Parkinson's disease
    Horellou, P
    Mallet, J
    [J]. MOLECULAR NEUROBIOLOGY, 1997, 15 (02) : 241 - 256
  • [26] The potential of GDNF as a treatment for Parkinson's disease - Commentary
    Hurelbrink, CB
    Barker, RA
    [J]. EXPERIMENTAL NEUROLOGY, 2004, 185 (01) : 1 - 6
  • [27] The use of cell-penetrating peptides as a tool for gene regulation
    Järver, P
    Langel, Ü
    [J]. DRUG DISCOVERY TODAY, 2004, 9 (09) : 395 - 402
  • [28] Integrin targeting using RGD-PEI conjugates for in vitro gene transfer
    Kunath, K
    Merdan, T
    Hegener, O
    Häberlein, H
    Kissel, T
    [J]. JOURNAL OF GENE MEDICINE, 2003, 5 (07) : 588 - 599
  • [29] Novel shielded transferrin-polyethylene glycol-polyethylenimine/DNA complexes for systemic tumor-targeted gene transfer
    Kursa, M
    Walker, GF
    Roessler, V
    Ogris, M
    Roedl, W
    Kircheis, R
    Wagner, E
    [J]. BIOCONJUGATE CHEMISTRY, 2003, 14 (01) : 222 - 231
  • [30] Adenovirus endocytosis via αv integrins requires phosphoinositide-3-OH kinase
    Li, EG
    Stupack, D
    Klemke, R
    Cheresh, DA
    Nemerow, GR
    [J]. JOURNAL OF VIROLOGY, 1998, 72 (03) : 2055 - 2061